Our Physicians

Michael P. Sherman, M.D., Ph.D.

FOUNDER AND MEDICAL DIRECTOR
OF CONTRA COSTA ONCOLOGY

Michael P. Sherman, M.D., Ph.D.

Michael P. Sherman, M.D., Ph. D. is board certified in Internal Medicine and Medical Oncology, graduating from Cornell University with distinction and honors. While pursuing his medical degree at the State University of New York at Syracuse, he simultaneously completed his Ph.D. thesis studying cancer-causing viruses. Dr. Sherman went on to complete his medical internship and residency training at Johns Hopkins Hospital in Baltimore, as well as a Medical Oncology Fellowship at the University of California, San Francisco (UCSF). He received post-graduate training at the Gladstone Institute of Virology and Immunology at UCSF. Dr. Sherman holds three U.S. patents and is the principal/secondary author of 27 original manuscripts and publications as well as eight reviews and book chapters. A nationally sought-after speaker on the subject of cancer treatment, he is also a frequent lecturer in the local community and participant in patient-oriented support groups. Dr. Sherman regularly attends national and international oncology meetings, including the San Antonio Breast Cancer Symposium, and is also an active leader and participant in patient-focused clinical trials.

Diana Superfin, M.D.

Diana Superfin, M.D.

Diana Superfin, M.D. is board certified in Medical Oncology and Hematology. Dr. Superfin attended Wake Forest University School of Medicine in North Carolina with the highest honors. Completing both her Internal Medicine internship and residency training at UC she went on to complete her Medical Oncology and Hematology fellowship at UC Davis Medical Center.

Dr. Superfin is the principal author of three research papers, one of which was presented at the Annual Meeting of the American Society of Hematology in 2005. Dr. Superfin is also fluent in Russian and Ukrainian languages. A frequent lecturer in the community, Dr. Superfin attends national and local oncology and hematology meetings and is actively involved in clinical trials.

Gauri Sharma, D.O.

Gauri Sharma, D.O.

Board certified in Internal Medicine, Oncology and board eligible in Hematology, Dr. Gauri Sharma is experienced in treating a broad range of hematological and oncologic diseases. She completed her undergraduate studies in Biopsychology and Cognitive Science from The University of Michigan in Ann Arbor, MI. After receiving her medical degree from Michigan State University College of Osteopathic Medicine, Dr. Sharma went on to complete her medical internship and residency in Internal Medicine at Lenox Hill Hospital in New York City. Her fellowship in Hematology/Oncology was completed at St. John Providence Hospital in Southfield, Michigan, where she also served as Chief Fellow.

Upon completion of her fellowship in 2015, she joined a private practice affiliated with the Troy Beaumont Hospital in Michigan, where she practiced hematology and oncology until joining Contra Costa Oncology this year.

Dr. Sharma is a published author in peer reviewed journals, and has also published research on sexual dysfunction in breast cancer patients. She regularly attends International Hematology and Oncology meetings. Dr. Sharma is also fluent in Hindi.

Tracie Watson, D.O.

Tracie Watson, D.O.

Tracie Watson, D.O. is board certified in Internal Medicine, Medical Oncology and Hematology. Dr. Watson completed her undergraduate studies at University of California, Berkeley, where she graduated with honors. After receiving her Masters of Science at Georgetown University, she earned her medical degree from Touro University of Osteopathic Medicine in California. Dr. Watson completed her medical internship and residency at Loyola University Medical Center in Maywood, Illinois, where she also earned her fellowship in Hematology and Medical Oncology.

Her philosophy of treatment is to look at the patient as a whole, with a focus on their individual needs and characteristics. She remains up to date with current treatment paradigms, and attends national meetings.